Tweet
Reinhardt called out for conflicts of interest
Apr. 8th, 2010 by Andrew Van Dam
Filed under: Conflicts of interest, Health journalism, Hospitals, Hot Health Headline, Public records
Bloggers and online journalists (Health Care Renewal, the nytpicker, Business Insider) have noticed that Princeton health economist Uwe Reinhardt, who writes for The New York Times? Economix blog and was the keynote speaker at Health Journalism 2009, earns $500,000 a year working for a number of health care companies, owns about $5 million in related stock, and thus appears to be in violation of The New York Times? conflict-of-interest policy. The conflicts are not yet listed on his Times bio, though the newspaper and Reinhardt both promise they will be soon.
snip
According to nytpicker, which seems to have come to the story first, Reinhardt is involved with at least five private health-related enterprises, for which he is being compensated with both cash and stock options. Those include Amerigroup Corporation, Boston Scientific, H&Q Healthcare Investors and H&Q Life Sciences Investors, and Legacy Hospital partners.
more here:
http://www.healthjournalism.org/blog...s-of-interest/
Apr. 8th, 2010 by Andrew Van Dam
Filed under: Conflicts of interest, Health journalism, Hospitals, Hot Health Headline, Public records
Bloggers and online journalists (Health Care Renewal, the nytpicker, Business Insider) have noticed that Princeton health economist Uwe Reinhardt, who writes for The New York Times? Economix blog and was the keynote speaker at Health Journalism 2009, earns $500,000 a year working for a number of health care companies, owns about $5 million in related stock, and thus appears to be in violation of The New York Times? conflict-of-interest policy. The conflicts are not yet listed on his Times bio, though the newspaper and Reinhardt both promise they will be soon.
snip
According to nytpicker, which seems to have come to the story first, Reinhardt is involved with at least five private health-related enterprises, for which he is being compensated with both cash and stock options. Those include Amerigroup Corporation, Boston Scientific, H&Q Healthcare Investors and H&Q Life Sciences Investors, and Legacy Hospital partners.
more here:
http://www.healthjournalism.org/blog...s-of-interest/
Comment